Vaccinome Landscape in Nearly 620 000 Patients With Diabetes - Takeaways - MDSpire

Vaccinome Landscape in Nearly 620 000 Patients With Diabetes

  • By

  • Francesca D’Addio

  • Elisa Lazzaroni

  • Maria Elena Lunati

  • Giuseppe Preziosi

  • Michele Ercolanoni

  • Giulio Turola

  • Chiara Marrocu

  • Giovanni Cicconi

  • Sudwaric Sharma

  • Simona Scarioni

  • Laura Montefusco

  • Ida Pastore

  • Paola Silvia Morpurgo

  • Antonio Rossi

  • Alessandra Gandolfi

  • Camilla Tinari

  • Giada Rossi

  • Moufida Ben Nasr

  • Cristian Loretelli

  • Roberta Maria Fiorina

  • Baldassarre Grassa

  • Rosa Terranova

  • Loredana Bucciarelli

  • Cesare Berra

  • Danilo Cereda

  • Gianvincenzo Zuccotti

  • Catia Rosanna Borriello

  • Paolo Fiorina

  • July 23, 2024

  • 0 min

Share

  • 1

    Type 1 and type 2 diabetes significantly increase the risk of infectious diseases, leading to higher hospitalization and mortality rates.

  • 2

    In a cohort of 618,396 patients with diabetes, immunization coverage for influenza was 44.6%, while coverage for other vaccines was notably lower.

  • 3

    Vaccination against influenza, zoster, and meningococcus resulted in a two-fold reduction in mortality risk and decreased hospitalizations among vaccinated patients.

  • 4

    Older patients with diabetes experienced a three-fold lower mortality risk and reduced hospitalizations for cardiac and pulmonary causes after vaccination.

  • 5

    The study highlights the need to improve immunization coverage in diabetes patients, as current rates are below recommended targets despite significant benefits.

Original Source(s)

Vaccinome Landscape in Nearly 620 000 Patients With Diabetes

  • by Francesca D’Addio, Elisa Lazzaroni, Maria Elena Lunati, Giuseppe Preziosi, Michele Ercolanoni, Giulio Turola, Chiara Marrocu, Giovanni Cicconi, Sudwaric Sharma, Simona Scarioni, Laura Montefusco, Ida Pastore, Paola Silvia Morpurgo, Antonio Rossi, Alessandra Gandolfi, Camilla Tinari, Giada Rossi, Moufida Ben Nasr, Cristian Loretelli, Roberta Maria Fiorina, Baldassarre Grassa, Rosa Terranova, Loredana Bucciarelli, Cesare Berra, Danilo Cereda, Gianvincenzo Zuccotti, Catia Rosanna Borriello, Paolo Fiorina

  • July 23, 2024

Related Content

AI Boosts Diabetic Eye Care Access

Recent study highlights how integrated AI-assisted DR screening in primary care clinics can improve access and decrease disparity

  • May 5, 2026

  • 3 min
Retinal Imaging Model Aids CAD Detection

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort

Diabetes Mellitus Coding in Retina

Age-related macular degeneration (AMD) is among the most common retinal diagnoses. Although the clinical features of the disease are well known, ICD-10 coding can be confusing if details such as stage, activity, and laterality are not clearly documented. Incomplete documentation may prompt questions about the medical necessity of diagnostic tests or intravitreal injections. This Q&A addresses common sources of confusion and offers practical guidance to support clear, accurate documentation.